Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With a rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers. Textiles are being considered as the logical choice for soft tissue repair including hernias, ligaments and tendons due to its fibrous nature of human body.

Market Analysis and Insights: Global Drug Integrated Polymer Fibers Market
The global Drug Integrated Polymer Fibers market was valued at US$ 61 in 2020 and will reach US$ 76 million by the end of 2027, growing at a CAGR of 3.8% during 2022-2027.

Global Drug Integrated Polymer Fibers Scope and Market Size
The global Drug Integrated Polymer Fibers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Integrated Polymer Fibers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Polylactic Acid
Polydioxanone
Polycaprolactone

Segment by Application
Drug Delivery
Orthopaedic Sutures
Vascular Stents
Vascular Grafts
Dermal Wound Healing

The Drug Integrated Polymer Fibers market is analysed and market size information is provided by regions (countries). Segment by Application, the Drug Integrated Polymer Fibers market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
TissueGen
Micro Engineering Solutions
Integrated Polymer Solutions